PT - JOURNAL ARTICLE AU - Sardinha, Daniele Melo AU - da Silva Luz, Andréa Maria AU - Almeida Carneiro, Kátia Raquel AU - Rodrigues Paixão, Mauro Daniel AU - de Sousa Bispo, Sebastião Kauã AU - Oliveira Andrade, Natasha Cristina AU - Alencar, Juliane Lima AU - de Nazaré Soares, Tamires AU - Santos Freitas, Joyce dos AU - Valois, Rubenilson Caldas AU - da Silva Ferreira, Ana Lúcia AU - Batista Lima, Karla Valéria AU - Costa Lima, Luana Nepomuceno Gondim TI - Epidemiological pattern of births from the largest surveillance database of live births in Brazil “SINASC” before and during the COVID-19 pandemic in the Brazilian Amazon AID - 10.1101/2022.09.02.22279455 DP - 2022 Jan 01 TA - medRxiv PG - 2022.09.02.22279455 4099 - http://medrxiv.org/content/early/2022/09/04/2022.09.02.22279455.short 4100 - http://medrxiv.org/content/early/2022/09/04/2022.09.02.22279455.full AB - The surveillance of live births in Brazil has been carried out since 1990 by the Information System on Live Births (SINASC), which was implemented by the Ministry of Health aiming at standardized registration on a national level. The state of Pará is part of the Brazilian Amazon, northern Brazil, which has several unique characteristics. Thus, the purpose of this study was to identify the epidemiological pattern of live births before and during the pandemic of COVID-19 in the state of Pará, 2016 to 2020. This is an ecological epidemiological time-series study, using epidemiological surveillance data from DATASUS, referring to the Live Births Information System (SINASC). These are data that have been treated by surveillance and are in aggregate format. The study population is the live births residing in the state of Pará, in the period from 2016 to 2020. The data collection instrument was the Declaration of Live Births (DLB). There were 689,454 live births, and the highest rates of births were and continued to remain in the Marajó II, Baixo Amazonas, Xingu, and Tapajós regions. The Metropolitan I and Araguaia regions were and continue to be the lowest rates in the state. Age of the mother 15 to 19 years old 22.29%, 20 to 24 years old 30.05% and 25 to 29 years old 22.58%, most of the single pregnancy type 98.32%, prenatal consultations, performed 7 or more 48.10%, followed by 4 to 6 consultations 33.98%, most presented 7 or more years of the study 48.10%, followed by 3 to 6 years 33.98%. Represented 51.21% male and 48.77% female. The occurrence of congenital anomalies represented 0.52% of live births. Another congenital malformation and deformity were the most prevalent at 25.53%, followed by Congenital deformities of the feet 14.90%, Other congenital malformations of the nervous system 14.84%, and Other congenital malformations 10.77%, Cleft lip, and cleft palate 8.88%, Other congenital malformations digestive tract 8.10%. The demographic transition has already occurred for several decades, including the reduction of fertility and birth rate, so our study showed that the reduction in the number of live births was already a reality in the country, but we emphasize that this reduction was enhanced by the pandemic. We observed greater adherence to prenatal care and a lower prevalence of low birth weight compared to other studies, but the limitation was the absence of studies in the same place of the research. Regarding data incompleteness, we emphasize the ignored fields that reflect the fragility in the surveillance of live births, which was reinforced by the literature.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Coordenacao de Aperfecoamento de Pessoal de Nivel Superior (CAPES) and Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:According to Resolution No. 510 of April 7, 2016, Article II, which deals with research that uses publicly accessible data, under Law No. 12,527 of November 18, 2011, Articles III (research that uses information in the public domain) and V (research in databases whose information is aggregated, without the possibility of individual identification), will not be registered or evaluated by the Ethics and Research Committee system. Thus, these types of studies are not recommended to be submitted for ethical review and can be freely conducted, since the publicly available data does not include data such as the names, phone numbers, and addresses of the participantsI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDATASUS https://datasus.saude.gov.br/